Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus. 2009

Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
Division of Swine Infectious Diseases, National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, No. 427 Maduan Street, Harbin 150001, Heilongjiang, China.

H1N1 and H3N2 are the dominant subtypes causing swine influenza in China and other countries. It is important to develop effective vaccines against both H1N1 and H3N2 subtypes of swine influenza virus (SIV). We examined the effects of a DNA vaccine expressing an influenza HA fused to three copies of murine complement C3d in mice. Plasmids encoding soluble HA (sHA), complete HA (tmHA), or a soluble fused form of HA (sHA-mC3d3) were constructed from the H3N2 subtype of SIV. The immune response was monitored by an enzyme-linked immunosorbent assay (ELISA), hemagglutination inhibition (HI) assays, and virus neutralization tests. Analysis of antibody titers indicated that immunization with HA-mC3d3 resulted in higher titers of anti-HA antibodies and higher antibody affinities, compared with serum from mice immunized with sHA or tmHA. Furthermore, the C3d fusion increased the Th2-biased immune response, by inducing IL-4 production. Splenocytes from mice immunized with sHA-mC3d3 produced about three-fold more IL-4 than did splenocytes from mice immunized with sHA or tmHA. Seven days post-challenge with homologous virus (H3N2), no virus was isolated from the mice immunized with HA-expressing plasmids. However, 10 days post-challenge with heterologous virus (H1N1), only mice immunized with sHA-mC3d3 had no virus or microscopic lesions in the kidneys and cerebrum. In conclusion, C3d enhanced antibody responses to hemagglutinin and protective immunity against SIV of different subtypes.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009976 Orthomyxoviridae Infections Virus diseases caused by the ORTHOMYXOVIRIDAE. Orthomyxovirus Infections,Infections, Orthomyxoviridae,Infections, Orthomyxovirus,Swine Influenza,Infection, Orthomyxoviridae,Infection, Orthomyxovirus,Influenza, Swine,Orthomyxoviridae Infection,Orthomyxovirus Infection
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin

Related Publications

Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
January 2010, Journal of virology,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
February 2003, Vaccine,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
February 2021, Nature communications,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
November 2003, Vaccine,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
August 2000, Nature immunology,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
January 2012, Acta virologica,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
January 2018, Frontiers in immunology,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
March 1999, Journal of virology,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
October 2019, Virology,
Guo-Xin Li, and Zhi-Jun Tian, and Hai Yu, and Yuan-Yuan Jin, and Shao-Hua Hou, and Yan-Jun Zhou, and Tian-Qiang Liu, and Shou-Ping Hu, and Guang-Zhi Tong
November 2020, Veterinary microbiology,
Copied contents to your clipboard!